Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 39 min ago
Peer-reviewedCC BY 4.0Frontiers in Pharmacology

Multi-omics identifies PCK1-associated immunometabolic regulation underlying the protective effects of sinomenine in vascular dementia

  • Wanling Ren1
  • Zipu Wang1
  • Weisi Yang2
  • Yuan Rao1
  • Zhiqing Qiu3
  • Jing Li1,4,5
  • Haining Ou1,4,5
5 affiliations
  1. 1Traditional Chinese Medicine Rehabilitation Research Team, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
  2. 2School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine
  3. 3The Fifth Affiliated Hospital of Guangzhou Medical University
  4. 4Rehabilitation Department, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
  5. 5Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine
Open at sourceDOICite

Abstract

Background: Vascular dementia (VaD) is one of the major causes of cognitive impairment among older adults. However, effective treatments that can modify the progression of the disease are still lacking. Emerging evidence indicates that metabolic remodeling in microglia influences inflammatory responses during vascular brain injury. Microglial immunometabolic regulation has therefore been proposed as an important contributor to the pathogenesis of vascular dementia (VaD).

Methods: Transcriptomic integration, WGCNA, network pharmacology, and single-nucleus RNA sequencing were combined to identify disease-associated microglial alterations and potential targets involved in sinomenine (SIN)-mediated regulation. The interaction between SIN and phosphoenolpyruvate carboxykinase 1 (PCK1) was investigated using molecular docking and molecular dynamics simulations. The biological effects of SIN were then validated in lipopolysaccharide (LPS)-stimulated BV2 microglia.

Results: Integrated analyses highlighted PCK1 as a potential mediator associated with SIN-induced metabolic regulation in VaD. snRNA-seq demonstrated expansion of metabolically stressed microglial states accompanied by PCK1-related metabolic alterations. Stable binding between SIN and PCK1 was supported by molecular docking and molecular dynamics simulations. In LPS-stimulated BV2 microglia, SIN suppressed inflammatory activation, restored PCK1 expression, attenuated inflammation-associated metabolic remodeling, improved cellular bioenergetics, and modulated metabolic redox-related parameters. SIN also enhanced adaptive stress responses through regulation of CRYAB, APOD, and HSPH1.

Conclusion: Collectively, these findings suggest that SIN alleviates VaD-associated microglial dysfunction by modulating PCK1-associated immunometabolic alterations. They expand the current understanding of the pharmacological actions of SIN and highlight microglial immunometabolic regulation as a potential therapeutic target for VaD.

Related

  1. Deep Learning-Based Spatial Profiling Identifies MET-Associated Immune Exclusion and Therapeutic Vulnerability Underlying Racial Disparities in Head and Neck Cancer
    Xinyu Cui, Fanghui Chen, Ashley McCook-Veal +7
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxivPMC
  2. Transcriptomic Profiling Identifies Hub Transcription Factors Associated with the Protective Effects of Licochalcone A Against HFD-Induced MASLD
    Shanshan Zhao, Bohan Lei, Rongxia Li +1
    NutrientsPeer-reviewedCC BY 4.0Epidemiology & public healthCrossref
  3. Protective and Reparative Effects of Naematelia aurantialba Ethanol Extract Against UV-Induced Skin Photoaging and Its Underlying Mechanisms
    Guanjie Peng, Bowen Sun, Sihui Chen +4
    Journal of Oleo SciencePeer-reviewedCC BYFull textGeneral medicineJ-STAGE
  4. Multi-organ proteomics identifies oxidative stress pathways underlying genetic and pharmacological SGLT2 suppression
    Marta Parente Nascimento, Ilyas Majid, Anu Arthy Murugan Karunagaran +13
    Redox BiologyPeer-reviewedCC BYFull textEndocrinology & metabolismDOAJ
  5. Integrated Transcriptomic Analysis Identifies a Ferroptosis-Related Gene Signature Underlying Macrophage Heterogeneity and Immune Dysregulation in Rheumatoid Arthritis Synovium
    Houchen Liu, Ruizhuo Zhang
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General medicineCrossref

Cite

BibTeXRIS
BibTeX
@article{ren2026multiomics,
  title = {{Multi-omics identifies PCK1-associated immunometabolic regulation underlying the protective effects of sinomenine in vascular dementia}},
  author = {Wanling Ren and Zipu Wang and Weisi Yang and Yuan Rao and Zhiqing Qiu and Jing Li and Haining Ou},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  month = oct,
  doi = {10.3389/fphar.2026.1979177},
  url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1979177/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Multi-omics identifies PCK1-associated immunometabolic regulation underlying the protective effects of sinomenine in vascular dementia
AU  - Wanling Ren
AU  - Zipu Wang
AU  - Weisi Yang
AU  - Yuan Rao
AU  - Zhiqing Qiu
AU  - Jing Li
AU  - Haining Ou
PY  - 2026
DA  - 2026/10/29
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1979177
UR  - https://www.frontiersin.org/articles/10.3389/fphar.2026.1979177/full
AB  - Background: Vascular dementia (VaD) is one of the major causes of cognitive impairment among older adults. However, effective treatments that can modify the progression of the disease are still lacking. Emerging evidence indicates that metabolic remodeling in microglia influences inflammatory responses during vascular brain injury. Microglial immunometabolic regulation has therefore been proposed as an important contributor to the pathogenesis of vascular dementia (VaD).  Methods: Transcriptomic integration, WGCNA, network pharmacology, and single-nucleus RNA sequencing were combined to identify disease-associated microglial alterations and potential targets involved in sinomenine (SIN)-mediated regulation. The interaction between SIN and phosphoenolpyruvate carboxykinase 1 (PCK1) was investigated using molecular docking and molecular dynamics simulations. The biological effects of SIN were then validated in lipopolysaccharide (LPS)-stimulated BV2 microglia.  Results: Integrated analyses highlighted PCK1 as a potential mediator associated with SIN-induced metabolic regulation in VaD. snRNA-seq demonstrated expansion of metabolically stressed microglial states accompanied by PCK1-related metabolic alterations. Stable binding between SIN and PCK1 was supported by molecular docking and molecular dynamics simulations. In LPS-stimulated BV2 microglia, SIN suppressed inflammatory activation, restored PCK1 expression, attenuated inflammation-associated metabolic remodeling, improved cellular bioenergetics, and modulated metabolic redox-related parameters. SIN also enhanced adaptive stress responses through regulation of CRYAB, APOD, and HSPH1.  Conclusion: Collectively, these findings suggest that SIN alleviates VaD-associated microglial dysfunction by modulating PCK1-associated immunometabolic alterations. They expand the current understanding of the pharmacological actions of SIN and highlight microglial immunometabolic regulation as a potential therapeutic target for VaD.
SN  - 1663-9812
ER  -